RNS Filings (Inside Information)

February 13, 2020 –  Indivior Announces FY 2019 Financial Results

October 15, 2019 – Indivior Raises FY 2019 Net Revenue and Net Income Guidance

July 11, 2019 – Indivior Raises FY 2019 Net Revenue and Net Income Guidance; Cash at H1 2019 Expected to be Approximately $985m

May 02, 2019 – Indivior PLC Q1 2019 Financial Results

Feb 14, 2019 – Indivior PLC FY 2018 Financial Results

Sep 26, 2018 – Indivior Provides Update on Key Business Drivers and Expectations

July 25, 2018 – Indivior H1 2018 Financial Results

July 11, 2018 – Indivior Sees FY18 Guidance Below Expectations

Mar 23, 2018 – Indivior Responds To Court Ruling in ANDA Litigation and Announces Intention To Appeal

Feb 15, 2018 – Indivior PLC Full Year 2017 Financial Results

Feb 1, 2018 – Indivior Provides Updates on Tax Position

Nov 30, 2017 – SUBLOCADE FDA Approval Press Release

Nov 30, 2017 – SUBLOCADE Fact Sheet

Sep 1, 2017 – Indivior Responds To Court Rulings in ANDA Litigation and Announces Intention To Appeal

July 27, 2017 – Indivior Half Year Financial Results

March 13, 2017 – Indivior RBP-7000 Top-line Results

February 22, 2017 – Indivior PLC FY 2016 Financial Results

November 2, 2016 – Nine Month Financial Results: Litigation Provision of $220m booked: Guidance raised

August 17, 2016 – RBP-6000 Phase 3 Top Line Results

July 29, 2016 – Indivior Half Year Financial Results